(Eng Sub) Losing Weight: If You Don’t Do These Two Things, You Will Definitely Fail
To lose weight, eat less and exercise? "I didn’t lose it that way" The 38kg weight-loss secret from a Seoul National University doctor
Search results for "Anti-Obesity Medications"
Do Wegovy and Mounjaro Count as Doping? WADA Monitors GLP-1 Drugs in Sports
GLP-1 (glucagon-like peptide-1) class medications, such as Novo Nordisk’s Wegovy and Eli Lilly’s Mounjaro, are increasingly recognized for benefits...
Losing Weight Fast on Wegovy or Mounjaro? How High-Protein Foods Prevent Rebound
Popular anti-obesity injections like Wegovy and Mounjaro reduce appetite and prolong feelings of fullness.
Rethinking the First Meal: Herbal Pharmacist Cho Seung-woo on Fasting, Morning Juice, and Sustainable Health
Advice on how to start the day has never been more conflicting. Intermittent fasting urges extended fasting windows,...
As the U.S. Reconsiders Direct-to-Consumer Drug Ads, What Lessons Should We Learn?
During a yearlong stay in the United States, one of the things that struck me most was how easy it is to come across...
Maximizing Weight Loss vs. Protecting the Heart: The Paradox of Modern Anti-Obesity Drugs
As global demand for anti-obesity medications surges, a fierce pharmaceutical race is underway to develop...
Weighed Just 40 kg: Choi Yoo-jung Recalls Severe Risks of Secretly Taking Diet Pills as a Trainee
Singer Choi Yoo-jung, a former member of the project girl group I.O.I, has revealed that she secretly relied on diet...
Misdiagnosing Low Testosterone: Why Fatigue and Low Libido May Signal Other Serious Medical Conditions
An increasing number of men are turning to male hormone supplements, but medical experts caution against assuming that...
Considering Wegovy for Weight Loss? South Korea's Drug Safety Ministry Warns It Is Not for Everyone
South Korea’s Ministry of Food and Drug Safety issued a strong warning on July 8 against the misuse and abuse of GLP-1...
GLP-1 Weight-Loss Drugs: Potential Metabolic Instability Linked to Long-Term Use
A new study suggests that the long-term administration of GLP-1 receptor agonists—the class of anti-obesity medications...